High pretransplantation soluble CD30 levels: impact in renal transplantation.

High pretransplantation soluble CD30 levels: impact in renal transplantation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

High pretransplantation soluble CD30 levels: impact in renal transplantation. Abstract Text:

C Giannoli,M C Bonnet,G Perrat,A Houillon,S Reydet,C Pouteil-Noble,E Villar,N ,E Morelon,V Dubois,C Giannoli,M C Bonnet,G Perrat,A Houillon,S Reydet,C Pouteil-Noble,E Villar,N ,E Morelon,V Dubois,

In a retrospective study, the impact of the level of pretransplantation soluble CD30 molecule (sCD30) was evaluated on 3 year transplant survival, as well as the number and grade of acute rejection episodes among kidney recipients engrafted between 2000 and 2002. One hundred and ninety sera of 190 patients sampled on the cross-match day were tested for sCD30 concentrations using an enzyme-linked immunosorbent assay (ELISA) kit (Biotest). For the analysis, a sCD30 cutoff level of 100 U/mL was chosen: 87 (46%) recipients had a level >100, and 103 (54%) <100. All cases (5) of immunological graft loss showed a high sCD30 level. The rate of biopsy-proven acute rejection was 26% in the sCD30 >100 group versus 22% in the sCD30 <100 groups. Among the first graft population (n = 157), the rate was 27% for sCD30 >100 versus 20% for the lower level. The difference was more important for grade II acute rejection (Banff criteria): 6/87 (7%) showed high sCD30 versus 2/103 (2%) with sCD30 <100. This analysis became significant for anti-HLA immunization: 11 (13%) recipients developed anti-HLA class II antibodies in the first group (sCD30 >100) versus 1 (1%) in the second group (sCD30 <100; P < .01). A high pretransplantation sCD30 was not a significant risk factor for an acute rejection episode, but it seemed to be more predictive for antibody-mediated acute rejection and immunological graft loss. However, many recipients showed an increased pretransplantation concentration without any rejection episode or graft loss. Consequently, sCD30 pregraft measurements cannot be used as a predictor for acute kidney rejection among our transplant center, nor as an aid to adapt the immunosuppressive regimen.

High pretransplantation soluble CD30 levels: impact in renal transplantation. Publishing Authors By Initials

C Giannoli,MC Bonnet,G Perrat,A Houillon,S Reydet,C Pouteil-Noble,E Villar,N ,E Morelon,V Dubois,C Giannoli,MC Bonnet,G Perrat,A Houillon,S Reydet,C Pouteil-Noble,E Villar,N ,E Morelon,V Dubois,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

High pretransplantation soluble CD30 levels: impact in renal transplantation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Transplantation proceedings

VOLUME: 39

Page Numbers: 2574-5

Journal Abbreviation: Transplant. Proc.

ISSN: 0041-1345

DAY: 23

MONTH: Oct

YEAR: 2007

High pretransplantation soluble CD30 levels: impact in renal transplantation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 243532

High pretransplantation soluble CD30 levels: impact in renal transplantation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: High pretransplantation soluble CD30 levels: impact in renal transplantation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for High pretransplantation soluble CD30 levels: impact in renal transplantation.

AFFILIATION: Histocompatibility Laboratory, EFS Rhône Alpes, 1-3 rue du Vercors, 69364 Lyon Cédex 07, France. catherine.giannoli@efs.sante.fr

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Transplant Proc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

High pretransplantation soluble CD30 levels: impact in renal transplantation Related Publications

• A biomechanical model of the pelvic cavity: first steps.
• A novel approach to clinical-radiological correlations: Anatomo-Clinical Overlapping Maps (AnaCOM): method and validation.
• A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch.
• Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
• Benchmarking in the eighteenth century.
• Bungendore health impact assessment: urban development in a rural setting.
• Clinical diagnostic criteria for dementia associated with Parkinson's disease.
• Cross-border referral for early breast cancer: an analysis of radiation fractionation patterns.
• Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.
• Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: A guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
• Direction of persistent ischemic mitral jet after restrictive valve annuloplasty: Implication for interpretation of perioperative echocardiography.
• Effects of acute exposure to aluminum on cognition in humans.
• Encephalitis following Mycoplasma pneumonia (2007: 6b). Acute disseminated encephalomyelitis.
• Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.
• High pretransplantation soluble CD30 levels: impact in renal transplantation.
• Hypoxia-inducible Factor Mediates Hypoxic and Tumor Necrosis Factor {alpha}-induced Increases in Tumor Necrosis Factor-{alpha} Converting Enzyme/ADAM17 Expression by Synovial Cells.
• Is PD-MCI a useful concept?
• Measurement of eicosanoids in cancer tissues.
• NSAIDs and cancer prevention: targets downstream of COX-2.
• Noninvasive cardiac output monitoring (NICOM): a clinical validation.
• Oxybutynin extended release and tolterodine immediate release : a health economic comparison.
• Polarization-sensitive full-field optical coherence tomography.
• Pure topographical disorientation following a right forceps major of the splenium lesion: a case study.
• Ras up-regulation of cyclooxygenase-2.
• Synthesis and biological evaluation of potential bisubstrate inhibitors of protein farnesyltransferase. Design and synthesis of functionalized imidazoles.
• Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.
• The needs of rural and urban young, middle-aged and older adults with a serious mental illness.
• Thiol-disulphide oxidoreductase modules in the low-GC Gram-positive bacteria.
• [Frontotemporal dementia]
• [In Process Citation]